NSE: APOLLOHOSP · 30 September 2026 · Dated market coverage
- The stock is -6.64% at ₹8,084.00.
- Likely reason:heavy volume-driven selling and technical correction
- Approximate traded value is₹1651.06 crore.
- It is -10.88% from its 52-week high and +20.72% from its 52-week low.
- The stock is being compared withNifty Pharmaalongside the Nifty 50.
Why Is Apollo Hospitals Enter. L Share Price Falling 6.64% Today?
Latest NSE EOD report: 2026-09-29. Today’s Volume: 2,042,383; 5-Day Avg. Volume: 793,600; 20-Day Avg. Volume: 401,707; Volume vs 20-Day Avg.: 5.08x; Delivery Quantity: 403,816; Delivery %: 66.29%; Number of Trades: 61,576.
Apollo Hospitals Enterprise Limited (APOLLOHOSP) fell sharply by 6.64% today, settling at ₹8,084.0 after opening at ₹8,618.5. The stock traded near the lower end of its intraday range of ₹8,055.0 to ₹8,625.0, accompanied by heavy selling pressure. Trading volumes surged dramatically, recording 2.57 times its 5-day average and 5.08 times its 20-day average, signaling aggressive institutional or large-ticket liquidation.
The broader market and healthcare sector faced a downbeat session, amplifying the downward momentum in Apollo Hospitals. The benchmark Nifty slipped 0.42%, while the Nifty Pharma sector index dropped 1.84%. Apollo’s steep decline outpaced the sector losses significantly, contributing to an extended 5-day correction of 9.96% and dragging the 20-day return down by 6.35%.
While no new fundamental catalyst emerged today to directly trigger the steep slide, the price action coincides with a broader phase of profit-taking and technical weakness following previous sessions of consecutive losses. Recent corporate filings show normal operational updates, including the filing of Q1FY27 results in August and the conclusion of its Annual General Meeting in late August, indicating that today’s sharp move is primarily driven by heavy volume-backed selling rather than fresh adverse news.
low confidence
- Intraday price drop of 6.64% to ₹8,084.0
- Volume surging to 5.08x of its 20-day average
- Broader Nifty Pharma sector down by 1.84%
Ownership & Transaction Activity
Recent NSE pledge/encumbrance disclosures: SUNEETA REDDY: Pledge Revoke — 150000 shares (17-Nov-2025); PCR INVESTMENTS LIMITED: Pledge Revoke — 2300000 shares (16-Oct-2025); K VISHWESHWAR REDDY: Pledge — 70000 shares (29-Sep-2025)
Source: NSE PIT disclosure
WittyTrades Data Insight
Price Position:The stock is near the lower end of the day’s trading range.
Move From Open:-6.20%.
Intraday Range:6.58% of the previous close.
5-Day Performance:-9.96%; 20-Day Performance:-6.35%.
Latest Company Developments
What Should Traders and Investors Watch Next?
- Sustainability of support near the ₹8,055 intraday low and psychological ₹8,000 mark
- Delivery percentage trends following today’s high-volume plunge (currently at 66.29%)
- Broader Nifty Pharma sector sentiment and recovery signals
Catalyst note:No single confirmed fundamental trigger was identified; the move reflects heavy volume-driven selling and technical weakness.
Frequently Asked Questions
What is the likely reason for today’s move?
The stock experienced a steep 6.64% drop accompanied by multi-fold volume spikes relative to its moving averages. In the absence of any fresh negative corporate catalysts today, the move appears to be driven by aggressive institutional liquidation and profit-taking amid a weak pharma sector.
Is trading volume elevated?
Today’s volume is 2,042,383. The latest 20-day average available is 401,707, equivalent to about 5.08x of the recent average.
Before acting on this stock
Consult your own investment adviser before acting on any security. If you are interested in stock research or other available research categories, review theWittyTrades subscription plans and research segments.
Article by:WittyTrades Research Desk